Sanofi Pasteur sends investigational flu vaccine to U.S. Health Dept.
SWIFTWATER — Giant vaccine producer Sanofi Pasteur has shipped 15,000 doses of an "investigational" vaccine to protect against avian flu to the U.S. Department of Health and Human Services.
The investigational vaccine, designed to protect against the H5N1 influenza strain of avian flu or "bird" flu, will be used in the National Institute of Health's clinical studies to determine "the optimal formulation of the vaccine," according to Sanofi.
The investigational doses include the use of aluminum hydroxide, that could increase the vaccine's effectiveness and enable the use of less antigen in each dose.
SWIFTWATER — Giant vaccine producer Sanofi Pasteur has shipped 15,000 doses of an "investigational" vaccine to protect against avian flu to the U.S. Department of Health and Human Services.
The investigational vaccine, designed to protect against the H5N1 influenza strain of avian flu or "bird" flu, will be used in the National Institute of Health's clinical studies to determine "the optimal formulation of the vaccine," according to Sanofi.
The investigational doses include the use of aluminum hydroxide, that could increase the vaccine's effectiveness and enable the use of less antigen in each dose.
posted by Faustus and FrankenKitty at 6:09 AM
0 Comments:
Post a Comment
<< Home